Role of PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation of vascular smooth muscle cells proliferation

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 9, Issue 3, 2009, Pages 172-180

  Isenović, Esma R ^a   Kedees, Mamdouh H ^b   Tepavčević, Snežana ^a   Milosavljević, Tijana ^a   Korićanac, Goran ^a   Trpković, Andreja ^a   Marche, Pierre ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c Sorbonne Universités   (France)

Author keywords

cPLA2; ERK1 2; Insulin; PI3K Akt; Proliferation; VSMCs

Indexed keywords

CYTOSOLIC PHOSPHOLIPASE A2; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE B;

ARTERY INJURY; ARTERY WALL; ATHEROSCLEROSIS; CELL ACTIVATION; CELL DAMAGE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CYTOSOL; DISEASE COURSE; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME RELEASE; HORMONAL REGULATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC REGULATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DEPHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL PROLIFERATION; HUMANS; INSULIN; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHOLIPASES A2, CYTOSOLIC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 73249149543     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152909789007034     Document Type: Review

References (86)

1. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 1993, 362, 801-809.
2. Campbell, J.H.; Black, M.J.; Campbell, G.R. In Blood cells and arteries in hypertension and atherosclerosis; Meyer, P., Marche, P., Eds.; Raven Press: New York, 1989; Vol. 19, pp. 15-33.
3. Beckman, J.A.; Creager, M.A.; Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 2, 287, 2570-2581.
4. Pyorala, M.; Miettinen, H.; Halonen, P.; Laakso, M.; Pyorala, K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow up results of the Helsinki Policemen Study. Arterioscler. Thromb. Vasc. Biol., 2000, 20, 538-544.
5. Nigro, J.; Osman, N.; Dart, A.M.; Little, P.J. Insulin resistance and atherosclerosis. Endocr. Rev., 2006, 27, 242-259.
6. Sesti, G.; Federici, M.; Lauro, D.; Sbraccia, P.; Lauro, R. Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms. Diabetes Metab. Res. Rev., 2001, 17, 363-373.
7. Arner, P.; Einarsson, K.; Ewerth, S.; Livingston, J. Studies of the human liver insulin receptor in noninsulin-dependent diabetes mellitus. J. Clin. Invest., 1986, 77, 1716-1718.
8. Cefalu, W.T. Insulin resistance: cellular and clinical concepts. Exp. Biol. Med.(Maywood), 2001, 226, 13-26.
9. De Luca, C.; Olefsky, M.J. Inflammation and insulin resistance. FEBS Lett., 2007, 582, 97-105.
10. Reasner, C.A. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors. J. Cardiovasc. Pharmacol., 2008, 52, 136-144.
11. Nilsson, J. Cytokines and smooth muscle cells in atherosclerosis. Cardiovasc. Res., 1993, 27, 1184-1190.
12. Sowers, J.R.; Epstein, M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension, 1995, 26, 869-879.
13. Colwell, J.A.; Jokl, R. In Diabetes Mellitus: Theory and Practice; Porte, D.; Sherwin, R.; Rifkin, H.; Eds.; Appleton and Lange: Norwalk, 1996.
14. Colwell, J.A., Lyons, T.J., Klein, R.L., Lopes-Virella, M. In The Diabetic Foot; Levin, M. J.; Ed.; Mosby: St. Louis, 1992, pp. 79-114.
15. Stout, R.W. Insulin and atherogenesis. Eur. J. Epidemiol., 1992, 8 (Suppl 1), 134-135.
16. King, G.L.; Buzney, S.M.; Kahn, C.R.; Hetu, N.; Buchwald, S.; Macdonald, S.G.; Rand, L.I. Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J. Clin. Invest., 1983, 71, 974-979.
17. Bornfeldt, K.E.; Gidlof, R.A.; Wasteson, A.; Lake, M.; Skottner, A.; Arnqvist, H.J. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia, 1991, 34, 307-313.
18. Jialal, I.; Crettaz, M.; Hachiya, H.L.; Kahn, C.R.; Moses, A.C.; Buzney, S.M.; King, G.L. Characterization of the receptors for insulin and the insulin-like growth factors on micro- and macrovascular tissues. Endocrinology, 1985, 117, 1222-1229.
19. Ekman, B.; Nystrom, F.; Arnqvist, H.J. Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes. Eur. J. Endocrinol., 2000, 143, 505-510.
20. Vicent, D.; Ilany, J.; Kondo, T.; Naruse, K.; Fisher, S.J.; Kisanuki, Y.Y.; Bursell, S.; Yanagisawa, M.; King, G.L.; Kahn, C.R. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J. Clin. Invest., 2003, 111, 1373-1380.
21. Zecchin, H.G.; Bezerra, R.M.; Carvalheira, J.B.; Carvalho-Filho, M.A.; Metze, K.; Franchini, K.G.; Saad, M.J. Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance--the obese middle-aged and the spontaneously hypertensive rats. Diabetologia, 2003, 46, 479-491.
22. Hyakukoku, M.; Higashiura, K.; Ura, N.; Murakami, H.; Yamaguchi, K.; Wang, L.; Furuhashi, M.; Togashi, N.; Shimamoto, K. Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats. Hypertens. Res., 2003, 26, 169-176.
23. Walsh, M.F.; Ali, S.S.; Sowers, J.R. Vascular insulin/insulin-like growth factor-1 resistance in female obese Zucker rats. Metabolism, 2001, 50, 607-612.
24. Jiang, Z.Y.; Lin, Y.W.; Clemont, A.; Feener, E.P.; Hein, K.D.; Igarashi, M.; Yamauchi, T.; White, M.F.; King, G.L. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest., 1999, 104, 447-457.
25. Kim, K.H.; Song, M.J.; Yoo, E.J.; Choe, S.S.; Park, S.D.; Kim, J.B. Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J. Biol. Chem., 2004, 279, 51999-52006.
26. Mounier, C.; Posner, B.I. Transcriptional regulation by insulin: from the receptor to the gene. Can. J. Physiol. Pharmacol., 2006, 84, 713-724.
27. Barthel, A.; Schmoll, D.; Unterman, T.G. FoxO proteins in insulin action and metabolism. Trends Endocrinol.Metab., 2005, 16, 183-189.
28. Eberle, D.; Hegarty, B.; Bossard, P.; Ferre, P.; Foufelle, F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie, 2004, 86, 839-848.
29. Myers, M.G. Jr.; Backer, J.M.; Sun, X.J.; Shoelson, S.; Hu, P.; Schlessinger, J.; Yoakim, M.; Schaffhausen, B.; White, M.F. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. Proc. Natl. Acad. Sci. USA, 1992, 89, 10350-10354.
30. Burgering, B.M.; Coffer, P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature, 1995, 376, 599-602.
31. Bellacosa, A.; Testa, J.R.; Staal, S.P.; Tsichlis, P.N. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science, 1991, 254, 274-277.
32. Cantley, L.C. The phosphoinositide 3-kinase pathway. Science, 2002, 296, 1655-1657.
33. Cross, D.A.; Alessi, D.R.; Cohen, P.; Andjelkovich, M.; Hemmings, B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature, 1995, 378, 785-789.
34. Dudek, H.; Datta, S.R.; Franke, T.F.; Birnbaum, M.J.; Yao, R.; Cooper, G.M.; Segal, R.A.; Kaplan, D.R.; Greenberg, M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 1997, 275, 661-665.
35. Kauffmann-Zeh, A.; Rodriguez-Viciana, P.; Ulrich, E.; Gilbert, C.; Coffer, P.; Downward, J.; Evan, G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature, 1997, 385, 544-548.
36. Cusi, K.; Maezono, K.; Osman, A.; Pendergrass, M.; Patti, M.E.; Pratipanawatr, T.; DeFronzo, R.A.; Kahn, C.R.; Mandarino, L.J. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest., 2000, 105, 311-320.
37. Minden, A.; Lin, A.; McMahon, M.; Lange-Carter, C.; Derijard, B.; Davis, R.J.; Johnson, G.L.; Karin, M. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science, 1994, 266, 1719-1723.
38. Taniguchi, C.M.; Emanuelli, B.; Kahn, C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol., 2006, 7, 85-96.
39. Shiojima, I.; Yefremashvili, M.; Luo, Z.; Kureishi, Y.; Takahashi, A.; Tao, J.; Rosenzweig, A.; Kahn, C.R.; Abel, E.D.; Walsh, K. Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J. Biol. Chem., 2002, 277, 37670-37677.
40. Latronico, M.V.; Costinean, S.; Lavitrano, M.L.; Peschle, C.; Condorelli, G. Regulation of cell size and contractile function by AKT in cardiomyocytes. Ann. N. Y. Acad. Sci., 2004, 1015, 250-260.
41. Shiojima, I.; Walsh, K. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev., 2006, 20, 3347-3365.
42. Kim, J.A.; Montagnani, M.; Koh, K.K.; Quon, M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation, 2006, 113, 1888-1904.
43. Balsinde, J.; Balboa, M.A.; Insel, P.A.; Dennis, E.A. Regulation and inhibition of phospholipase A2. Annu. Rev. Pharmacol. Toxicol., 1999, 39, 175-189.
44. Gijon, M.A.; Spencer, D.M.; Leslie, C.C. Recent advances in the regulation of cytosolic phospholipase A(2). Adv. Enzyme Regul., 2000, 40, 255-268.
45. Chakraborti, S. Phospholipase A(2) isoforms: a perspective. Cell Signal., 2003, 15, 637-665.
46. Nakano, T.; Ohara, O.; Teraoka, H.; Arita, H. Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett., 1990, 261, 171-174.
47. Sudar, E.; Velebit, J.; Gluvic, Z.; Zakula, Z.; Lazic, E.; Vuksanovic-Topic, L.; Putnikovic, B.; Neskovic, A.; Isenovic, E.R. Hypothetical mechanism of sodium pump regulation by estradiol under primary hypertension. J. Theor. Biol., 2008, 251, 584-592.
48. Zakula, Z.; Koricanac, G.; Putnikovic, B.; Markovic, L.; Isenovic, E.R. Regulation of the inducible nitric oxide synthase and sodium pump in type 1 diabetes. Med. Hypotheses, 2007, 69, 302-306.
49. Clark, J.D.; Milona, N.; Knopf, J.L. Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc. Natl. Acad. Sci. USA, 1990, 87, 7708-7712.
50. Balboa, M.A.; Balsinde, J.; Jones, S.S.; Dennis, E.A. Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells. J. Biol. Chem., 1997, 272, 8576-8580.
51. Tang, J.; Kriz, R.W.; Wolfman, N.; Shaffer, M.; Seehra, J.; Jones, S.S. A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. J. Biol. Chem., 1997, 272, 8567-8575.
52. Kramer, R.M.; Roberts, E.F.; Manetta, J.; Putnam, J.E. The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem., 1991, 266, 5268-5272.
53. Oka, S.; Arita, H. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J. Biol. Chem., 1991, 266, 9956-9960.
54. LaPointe, M.C.; Isenovic, E. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension, 1999, 33, 276-282.
55. Montagnani, M.; Golovchenko, I.; Kim, I.; Koh, G.Y.; Goalstone, M.L.; Mundhekar, A.N.; Johansen, M.; Kucik, D.F.; Quon, M.J.; Draznin, B. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J. Biol. Chem., 2002, 277, 1794-1799.
56. Isenovic, E.R.; Fretaud, M.; Koricanac, G.; Sudar, E.; Velebit, J.; Dobutovic, B.; Marche, P. Insulin regulation of proliferation involves activation of Akt and Erk1/2 signaling pathways in vascular smooth muscle cells. Exp. Clin. Endocrinol. Diabetes, 2008, 116, 1-6.
57. Lin, X.L.; Lin, Y.Z.; Koelsch, G.; Gustchina, A.; Wlodawer, A.; Tang, J. Enzymic activities of two-chain pepsinogen, two-chain pepsin, and the amino-terminal lobe of pepsinogen. J. Biol. Chem., 1992, 267, 17257-17263.
58. Nakamura, T.; Lin, L.L.; Kharbanda, S.; Knopf, J.; Kufe, D. Macrophage colony stimulating factor activates phosphatidylcholine hydrolysis by cytoplasmic phospholipase A2. EMBO J., 1992, 11, 4917-4922.
59. Wang, C.C.; Gurevich, I.; Draznin, B. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes, 2003, 52, 2562-2569.
60. Xi, X.P.; Graf, K.; Goetze, S.; Hsueh, W.A.; Law, R.E. Inhibition of MAP kinase blocks insulin-mediated DNA synthesis and transcriptional activation of c-fos by Elk-1 in vascular smooth muscle cells. FEBS Lett, 1997, 417, 283-286.
61. Ross, R. Cell biology of atherosclerosis. Annu. Rev. Physiol., 1995, 57, 791-804.
62. Isenovic, E.R.; Fretaud, M.; Dobutovic, B.; Sudar, E.; Smiljanic, K.; Zaric, B.; Trpkovic, A.; Marche, P. A novel hypothesis regarding the possible involvement of cytosolic phospholipase 2 in insulin-stimulated proliferation of vascular smooth muscle cells. Cell Biol. Int., 2009, 33, 386-392.
63. Taha, C.; Klip, A. The insulin signaling pathway. J. Membr. Biol., 1999, 169, 1-12.
64. Boulton, T.G.; Nye, S.H.; Robbins, D.J.; Ip, N.Y.; Radziejewska, E.; Morgenbesser, S.D.; DePinho, R.A.; Panayotatos, N.; Cobb, M.H.; Yancopoulos, G.D. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell, 1991, 65, 663-675.
65. Draznin, B.; Chang, L., Leitner, J.W., Takata, Y., Olefsky, J.M. Insulin activates p21Ras and guanine nucleotide releasing factor in cells expressing wild type and mutant insulin receptors. J. Biol. Chem., 1993, 268, 19998-20001.
66. Hayashi, K.; Saga, H.; Chimori, Y.; Kimura, K.; Yamanaka, Y.; Sobue,K. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J. Biol. Chem., 1998, 273, 28860-28867.
67. Yin, X.; Polidano, E.; Faverdin, C.; Marche, P. Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2. J. Hypertens., 2005, 23, 337-350.
68. Isenovic, E.R.; Meng, Y.; Jamali, N.; Milivojevic, N.; Sowers, J.R. Ang II attenuates IGF-1-stimulated Na+, K(+)-ATPase activity via PI3K/Akt pathway in vascular smooth muscle cells. Int. J. Mol. Med., 2004, 13, 915-922.
69. Geng,Y.J.;Libby, P. Progression of atheroma: a struggle between death andprocreation.Arterioscler.Thromb. Vasc.Biol.,2002, 22, 1370-1380.
70. Shepherd, P.R.; Nave, B.T.; Rincon, J.; Haigh, R.J.; Foulstone, E.; Proud, C.; Zierath, J.R.; Siddle, K.; Wallberg-Henriksson, H. Involvement of phosphoinositide 3-kinase in insulin stimulation of MAP-kinase and phosphorylation of protein kinase-B in human skeletal muscle: implications for glucose metabolism. Diabetologia, 1997, 40, 1172-1177.
71. Isenovic, E.R.; Fretaud, M.; Dobutovic, B.; Sudar, E.; Smiljanic, K.; Zaric, B.; Trpkovic, A.; Marche, P. A novel hypothesis regarding the possible involvement of cytosolic phospholipase 2 in insulin-stimulated proliferation of vascular smooth muscle cells. Cell Biol. Int., 2009, 33(3), 386-392.
72. Avena, R.; Mitchell, M.E.; Neville, R.F.; Sidawy, A.N. The additive effects of glucose and insulin on the proliferation of infragenicular vascular smooth muscle cells. J. Vasc. Surg., 1998, 28, 1033-1038; discussion 1038-1039.
73. Goetze, S.; Kintscher, U.; Kawano, H.; Kawano, Y.; Wakino, S.; Fleck, E.; Hsueh, W.A.; Law, R.E. Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cells. J. Biol. Chem., 2000, 275, 18279-18283.
74. Fukuda, N.; Satoh, C.; Hu, W.Y.; Nakayama, M.; Kishioka, H.; Kanmatsuse, K. Endogenous angiotensin II suppresses insulin signaling in vascular smooth muscle cells from spontaneously hypertensive rats. J. Hypertens., 2001, 19, 1651-1658.
75. Isenovic, E.; Muniyappa, R.; Milivojevic, N.; Rao, Y.; Sowers, J.R. Role of PI3-kinase in isoproterenol and IGF-1 induced ecNOS activity. Biochem. Biophys. Res. Commun., 2001, 285, 954-958.
76. Silfani, T.N.; Freeman, E.J. Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells. Arch. Biochem. Biophys., 2002, 402, 84-93.
77. Anderson, K.M.; Roshak, A.; Winkler, J.D.; McCord, M.; Marshall, L.A. Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells. J. Biol. Chem., 1997, 272, 30504-30511.
78. Longo, W.E.; Grossmann, E.M.; Erickson, B.; Panesar, N.; Mazuski, J.E.; Kaminski, D.L. The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells. J. Surg. Res., 1999, 84, 51-56.
79. Lin, L.L.; Wartmann, M.; Lin, A.Y.; Knopf, J.L.; Seth, A.; Davis, R.J. cPLA2 is phosphorylated and activated by MAP kinase. Cell, 1993, 72, 269-278.
80. Freeman, E.J.; Ruehr, M.L.; Dorman, R.V. ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells. Am. J. Physiol., 1998, 274, C282-288.
81. Muthalif, M.M.; Benter, I.F.; Karzoun, N.; Fatima, S.; Harper, J.; Uddin, M.R.; Malik, K.U. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin- dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA, 1998, 95, 12701-12706.
82. Gluck, N.; Schwob, O.; Krimsky, M.; Yedgar, S. Activation of cytosolic phospholipase A2 and fatty acid transacylase is essential but not sufficient for thrombin-induced smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol., 2008, 294, C1597-1603.
83. Saward, L.; Zahradka, P. Angiotensin II activates phosphatidylinositol 3-kinaseinvascular smoothmuscle cells. Circ. Res., 1997, 81, 249-257.
84. Touyz, R.M.; Schiffrin, E.L. Insulin-induced Ca2+ transport is altered in vascular smooth muscle cells of spontaneously hypertensive rats. Hypertension, 1994, 23, 931-935.
85. Carpenter,C.L.; Cantley, L.C. Phosphoinositide 3-kinase and the regulation of cell growth. Biochim. Biophys. Acta, 1996, 1288, M11-16.
86. Downes, C.P.; Carter, A.N. Phosphoinositide 3-kinase: a new effector in signal transduction? Cell Signal., 1991, 3, 501-513.